Amelie Boquoi

Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone Induction Therapy for Transplant-Eligible Newly Diagnosed Multiple Myeloma: Final Part 1 Analysis of the GMMG-HD7 Trial

K. Elias, Uta Bertsch, Ema Požek et al. · Journal of Clinical Oncology · 2024 · 62 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

<i>De Novo</i> Sequencing of Antibody Light Chain Proteoforms from Patients with Multiple Myeloma

Mathieu Dupré, Magalie Duchateau, Rebecca Sternke‐Hoffmann et al. · Analytical Chemistry · 2021 · 48 citations · Full text

Life Sciences, Molecular Biology, Molecular Diagnostics +16

Reversible cell cycle inhibition and premature aging features imposed by conditional expression of p16^Ink4a

Amelie Boquoi, Sanjeevani Arora, Tina Chen et al. · Aging Cell · 2014 · 47 citations · Full text

Education, Cell Biology, Molecular Genetics +17

p16Ink4a inhibits histologic progression and angiogenic signaling in min colon tumors

Steven L. Gibson, Amelie Boquoi, Tina Chen et al. · Cancer Biology & Therapy · 2005 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +17

Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease

Rebecca Sternke‐Hoffmann, Amelie Boquoi, David Lopez y Niedenhoff et al. · PeerJ · 2020 · 22 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17